Rockwell Automation (ROK) Form 4: 1,257 RSUs Granted to CFO
Rhea-AI Filing Summary
Reporting person Christian E. Rothe, Senior Vice President and Chief Financial Officer of Rockwell Automation (ROK), reported receipt of 1,257 restricted stock units (RSUs) on 08/19/2025. Each RSU represents a contingent right to one share of common stock and vests in three substantially equal annual installments beginning on the date exercisable. Following the reported acquisition, Mr. Rothe beneficially owns 8,530 shares of Rockwell Automation common stock. The Form 4 was signed by an attorney-in-fact on 08/21/2025. All holdings and grant details are shown on the filing; no derivative sales or cash purchases were reported.
Positive
- Acquisition of 1,257 RSUs documented on 08/19/2025, indicating executive equity alignment with shareholders
- Beneficial ownership increased to 8,530 shares following the reported transaction
- Vesting schedule disclosed: RSUs vest in three substantially equal annual installments beginning on the date exercisable
Negative
- None.
Insights
TL;DR: CFO received 1,257 RSUs that vest over three years, increasing his beneficial ownership to 8,530 shares.
The filing documents a routine equity award to a named executive officer rather than a market purchase or sale. The award is structured as restricted stock units that convert to common shares on vesting, with vesting occurring in three substantially equal annual installments after the date exercisable. For governance reviewers, this is a common retention and compensation mechanism aligning executive interests with shareholders; the filing provides clear counts and vesting schedule but does not disclose grant fair value or percent of outstanding shares.
TL;DR: Insider reported an equity grant of 1,257 RSUs (no cash price), now holding 8,530 shares beneficially.
From a reporting and compliance perspective, the Form 4 records a non-derivative acquisition via restricted stock units (transaction code indicated as M) and lists the conversion to common stock on vesting. The filing is timely and signed by an attorney-in-fact. It discloses precise share counts and vesting cadence but does not include information on grant valuation or any contemporaneous open-market transactions.